文献速递胃肠动力与功能性疾病

美国、加拿大和英国成人Rome IV功能性肠病患病率

Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.
PubMed 文献 · Gastroenterology · 2020-01-07

该多国人群调查纳入5931名美国、加拿大和英国成人,使用Rome IV诊断问卷评估功能性肠病(FBD)患病率。校正后任何Rome IV FBD患病率为28.6%-31.7%,IBS为4.4%-4.8%,功能性便秘为7.9%-8.6%。FBD患者生活质量显著降低且消化科就诊更多,Rome IV较Rome III使IBS患病率减半。

要点

  • 超过1/4成人符合Rome IV功能性肠病标准。
  • Rome IV较Rome III使IBS患病率减半(4.6% vs 9.0%)。
  • FBD患者生活质量下降且消化科就诊增加。

核心结论

  • 普通成人中超过四分之一符合Rome IV功能性肠病诊断标准。
  • 从Rome III改为Rome IV使IBS患病率减半,但功能性便秘和功能性腹泻患病率增加。

研究设计与样本

  • 基于美国、加拿大和英国成人的多国人群调查,共5931名有效应答者(49.2%女性,平均年龄47.4岁,范围18-92岁)。
  • 调查工具包括Rome IV诊断问卷、Rome III IBS和便秘问题以及SF-8生活质量问卷。

主要发现

  • 校正后Rome IV FBD患病率在三国相似:IBS为4.4%-4.8%,功能性便秘为7.9%-8.6%,功能性腹泻为3.6%-5.3%,功能性腹胀或膨隆为2.0%-3.9%,阿片类药物所致便秘为1.1%-1.9%,未特定FBD为7.5%-10.0%,任何Rome IV FBD为28.6%-31.7%。
  • FBD在老年人中较少见,除功能性腹泻外所有FBD在女性中更常见。
  • IBS按Rome IV的患病率仅为Rome III的一半(总体4.6% vs 9.0%),主要因Rome IV疼痛频率最低要求更高。
  • 功能性腹泻和功能性便秘按Rome IV比Rome III更常见。
  • FBD患者生活质量显著降低,且报告消化科医生咨询次数多于其他受试者。

临床怎么用

  • 临床评估功能性肠病时应采用Rome IV标准,注意其较Rome III降低IBS诊断率但提高功能性便秘和功能性腹泻诊断率。
  • 对功能性肠病患者应关注生活质量下降及消化科就诊需求增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Little is known about the population prevalence or demographic distributions of Rome IV functional bowel disorders (FBDs) or their effects on quality of life. We examined these in a multinational survey. METHODS: We analyzed data from a population-based survey of adults in the United States, Canada, and United Kingdom (5931 valid responders; 49.2% female; mean age, 47.4 years; range, 18-92 years). The survey included the Rome IV Diagnostic Questionnaire, Rome III irritable bowel syndrome (IBS) and constipation questions, and the SF-8 quality of life questionnaire. RESULTS: The prevalence values of census-adjusted Rome IV FBDs were similar among the 3 countries; ranges were: 4.4%-4.8% for IBS, 7.9%-8.6% for functional constipation, 3.6%-5.3% for functional diarrhea, 2.0%-3.9% for functional bloating or distention, 1.1%-1.9% for opioid-induced constipation, 7.5%-10.0% for unspecified FBDs, and 28.6%-31.7% for any Rome IV FBD. FBDs were less common in older individuals, and all except functional diarrhea were more common in women. IBS was only half as prevalent by Rome IV as by Rome III criteria (4.6% vs 9.0% overall), primarily due to higher Rome IV minimum pain frequency. Functional diarrhea and functional constipation were more prevalent by Rome IV than Rome III criteria. Subjects with FBD had significant reductions in quality of life and reported more gastrointestinal doctor consultations than other subjects. CONCLUSIONS: More than 1 in 4 adults in the general population meet the Rome IV criteria for FBDs. These disorders affect quality of life and increase use of gastrointestinal health care. The switch from Rome III to Rome IV criteria reduces the prevalence of IBS by half, but increases the prevalence of functional constipation and functional diarrhea.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Palsson OS, Whitehead W, Törnblom H, et al. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom. Gastroenterology. 2020. PMID: 31917991. doi:10.1053/j.gastro.2019.12.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。